Wells Fargo & Company Raises Glaukos (NYSE:GKOS) Price Target to $160.00
Glaukos (NYSE:GKOS – Free Report) had its price objective boosted by Wells Fargo & Company from $153.00 to $160.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical instruments supplier’s stock. A number of other research analysts have also recently commented on GKOS. Truist Financial upped their […]
Glaukos (NYSE:GKOS – Free Report) had its price objective boosted by Wells Fargo & Company from $153.00 to $160.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical instruments supplier’s stock. A number of other research analysts have also recently commented on GKOS. Truist Financial upped their […]
